BOARD OF DIRECTORS

MolecuLight is guided by a board of directors who has achieved success in various companies within the healthcare industry where they provided business perspectives and insights for the advancement of those companies.

Bill

William J. Wignall

Chairman of the board
President & CEO
Sangoma Technologies
Bill is currently the President and CEO of Sangoma Technologies, a publicly traded company based in Toronto, Canada. He offers a highly global scope, having worked and lived in many international settings. He is experienced in all company sizes (start-up/SME/large/multi-national) and in various modes of operation including both rapid growth and turn-around. Bill is also an ICD certified Director (ICD.D) and a graduate of their Directors Education Program.

Gordie

Gordie Nye

Director
REVA
Director/Senior Advisor
MuseAmi
Gordie is currently the CEO of R2 Dermatology, a development stage medical device company. He also served as CEO of ZELTIQ Aesthetics, a medical device company, from September 2009 to April 2012. Previously he was the general partner of Prism Venture Partners, a venture capital firm, where he was a member of the life sciences investment team. Gordie holds a BSBA and MBA from the Amos Tuck School of Business at Dartmouth College.

Sam

Sam Ifergan

President
IGAN Partners
Sam is the President and Partner at iGan Partners, a growth capital firm that invests in early stage software/internet and medical device/healthcare IT companies. Sam previously co-founded VisualSonics Inc., a company dedicated to preclinical imaging. He sits on the board of various companies including healthcare/medical device related companies and is also a member of the YPO-Toronto chapter.

Stewart

Stuart Foster, PhD

Founder
VisualSonics
Stuart is a senior scientist at Sunnybrook Health Sciences Centre and Professor (Department of Medical Biophysics, University of Toronto). He is the founder and former Chairman of VisualSonics Inc. Stuart oversaw all aspects of the growth of the company from a fledgling start-up to revenue in excess of $25 million and participated in a successful exit. He has served on the Board of Directors of the National Cancer Institute of Canada and as Chairman of its Committee on Research (ACOR).

Ralph

Ralph S. DaCosta, PhD

Founder, CSO
Ralph is the Cancer Care Ontario Research Chair in Cancer Imaging and a Principal Investigator at the Ontario Cancer Institute in Princess Margaret Hospital. His expertise is in developing optical molecular imaging and molecular probe technologies for clinical applications in disease diagnosis and treatment.